Considerations to accelerating and maximize the preclinical studies to a safe and effective COVID-19 vaccine
<p>The emergence of novel coronavirus-2019 (COVID-19) by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus and its rapid spread across the world have triggered a global health emergency without preceding. From the first report of COVID-19 at Wuhan city of China in December 201...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | |
| Опубликовано: |
Journal of Vaccines and Immunology - Peertechz Publications,
2021-01-25.
|
| Предметы: | |
| Online-ссылка: | Connect to this object online. |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | peertech__10_17352_jvi_000037 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Reynaldo Oliva-Hernández |e author |
| 245 | 0 | 0 | |a Considerations to accelerating and maximize the preclinical studies to a safe and effective COVID-19 vaccine |
| 260 | |b Journal of Vaccines and Immunology - Peertechz Publications, |c 2021-01-25. | ||
| 520 | |a <p>The emergence of novel coronavirus-2019 (COVID-19) by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus and its rapid spread across the world have triggered a global health emergency without preceding. From the first report of COVID-19 at Wuhan city of China in December 2019 until today there has been an outbreak of COVID-19 around the world, with 97, 831, 595 confirmed cases and 2, 120, 877 death cases [1,2] and this number keeps growing.</p><p><br></p> | ||
| 540 | |a Copyright © Reynaldo Oliva-Hernández et al. | ||
| 546 | |a en | ||
| 655 | 7 | |a Opinion |2 local | |
| 856 | 4 | 1 | |u https://doi.org/10.17352/jvi.000037 |z Connect to this object online. |